Beta glucan market is expected to witness significant growth due to the increasing consumer awareness regarding the health benefits of beta glucan. The growing demand for functional foods and dietary supplements that incorporate beta glucan is also driving the market growth. Additionally, the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is further fueling the demand for beta glucan as a nutritional supplement.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Source, Product, Application |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Biotec Pharmacon ASA, Biothera Pharmaceticals, Ceapro, Immunomedics, Super Beta Glucan, DSM NV, Tate & Lyle plc, Groupe Soufflet SA, Zilor Inc, Cargill Incorporated, Frutarom, GlycaNova AS, Lesaffre Human Care, Garuda International, Millipore Sigma |
However, the high cost associated with the production of beta glucan is a major restraint for the market. This can hinder the market growth as it may limit the affordability of beta glucan products for consumers. Furthermore, regulatory challenges and stringent guidelines for the use of beta glucan in various food and pharmaceutical products can also pose a challenge for market players looking to expand their product offerings.